EP2535330A3
(en)
*
|
2006-10-23 |
2012-12-26 |
Takeda Pharmaceutical Company Limited |
Iminopyridine derivative and use thereof
|
US7638541B2
(en)
|
2006-12-28 |
2009-12-29 |
Metabolex Inc. |
5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
|
EP2185544B1
(en)
|
2007-07-19 |
2014-11-26 |
Cymabay Therapeutics, Inc. |
N-azacyclic substituted pyrrole, pyrazole, imidazole, triazole and tetrazole derivatives as agonists of the rup3 or gpr119 for the treatment of diabetes and metabolic disorders
|
US8481569B2
(en)
*
|
2008-04-23 |
2013-07-09 |
Takeda Pharmaceutical Company Limited |
Iminopyridine derivatives and use thereof
|
CN102066327B
(zh)
*
|
2008-04-23 |
2013-05-29 |
武田药品工业株式会社 |
亚氨基吡啶衍生物及其用途
|
US20110039892A1
(en)
*
|
2008-04-23 |
2011-02-17 |
Takeda Pharmaceutical Company Limited |
Iminopyridine derivative and use thereof
|
AU2013206248B2
(en)
*
|
2008-06-27 |
2016-06-23 |
Xenon Pharmaceuticals Inc. |
Organic compounds
|
AU2011265439B2
(en)
*
|
2008-09-02 |
2012-09-20 |
Novartis Ag |
Picolinamide derivatives as kinase inhibitors
|
ES2551900T3
(es)
|
2008-09-02 |
2015-11-24 |
Novartis Ag |
Derivados de picolinamida como inhibidores de cinasa
|
CA2743134A1
(en)
|
2008-11-10 |
2010-05-14 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
CA3013000C
(en)
|
2008-12-19 |
2022-12-13 |
Vertex Pharmaceuticals Incorporated |
Pyrazine derivatives useful as inhibitors of atr kinase
|
ES2544452T3
(es)
*
|
2008-12-19 |
2015-08-31 |
Genentech, Inc. |
Compuestos heterocíclicos y métodos de uso
|
PA8852901A1
(es)
|
2008-12-22 |
2010-07-27 |
Lilly Co Eli |
Inhibidores de proteina cinasa
|
AU2010243353B2
(en)
*
|
2009-04-30 |
2014-09-11 |
Astex Therapeutics Limited |
Imidazole derivatives and their use as modulators of Cyclin dependent Kinases
|
AR077468A1
(es)
|
2009-07-09 |
2011-08-31 |
Array Biopharma Inc |
Compuestos de pirazolo (1,5 -a) pirimidina sustituidos como inhibidores de trk- quinasa
|
WO2011041154A1
(en)
|
2009-10-01 |
2011-04-07 |
Metabolex, Inc. |
Substituted tetrazol-1-yl-phenoxymethyl-thiazol-2-yl-piperidinyl-pyrimidine salts
|
SG182737A1
(en)
*
|
2010-01-27 |
2012-08-30 |
Pharma Ltd Ab |
Polyheterocyclic compounds highly potent as hcv inhibitors
|
US8247436B2
(en)
|
2010-03-19 |
2012-08-21 |
Novartis Ag |
Pyridine and pyrazine derivative for the treatment of CF
|
WO2011124580A1
(en)
|
2010-04-07 |
2011-10-13 |
F. Hoffmann-La Roche Ag |
Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use
|
JP2013529200A
(ja)
|
2010-05-12 |
2013-07-18 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
Atrキナーゼ阻害剤として有用な化合物
|
AU2011253021A1
(en)
|
2010-05-12 |
2012-11-29 |
Vertex Pharmaceuticals Incorporated |
2 -aminopyridine derivatives useful as inhibitors of ATR kinase
|
WO2011143425A2
(en)
|
2010-05-12 |
2011-11-17 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
US8969356B2
(en)
|
2010-05-12 |
2015-03-03 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of ATR kinase
|
EP2569313A1
(en)
|
2010-05-12 |
2013-03-20 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
JP2013526539A
(ja)
|
2010-05-12 |
2013-06-24 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
Atrキナーゼ阻害剤として有用なピラジン
|
EP2627650A2
(en)
|
2010-05-26 |
2013-08-21 |
Merck Sharp & Dohme Corp. |
N-phenyl imidazole carboxamide inhibitors of 3-phosphoinositide-dependent protein kinase-1
|
CA2803802A1
(en)
|
2010-06-23 |
2011-12-29 |
Vertex Pharmaceuticals Incorporated |
Pyrrolo- pyrazine derivatives useful as inhibitors of atr kinase
|
CA2802541A1
(en)
|
2010-06-23 |
2011-12-29 |
Metabolex, Inc. |
Compositions of 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
|
EP2590968A1
(en)
*
|
2010-07-06 |
2013-05-15 |
Novartis AG |
Cyclic ether compounds useful as kinase inhibitors
|
MX2013003101A
(es)
|
2010-09-17 |
2013-09-26 |
Purdue Pharma Lp |
Compuestos de piridina y sus usos.
|
AU2011311238A1
(en)
|
2010-10-05 |
2013-04-04 |
Purdue Pharma L.P. |
Quinazoline compounds as sodium channel blockers
|
US8987307B2
(en)
|
2011-03-03 |
2015-03-24 |
Hoffmann-La Roche Inc. |
3-amino-pyridines as GPBAR1 agonists
|
UY33930A
(es)
*
|
2011-03-04 |
2012-10-31 |
Novartis Ag |
Inhibidores novedosos de quinasas
|
EP2694498B1
(en)
|
2011-04-05 |
2016-03-30 |
Vertex Pharmaceuticals Incorporated |
Aminopyrazine compounds useful as inhibitors of tra kinase
|
EP2723747A1
(en)
|
2011-06-22 |
2014-04-30 |
Vertex Pharmaceuticals Inc. |
Compounds useful as inhibitors of atr kinase
|
US9309250B2
(en)
|
2011-06-22 |
2016-04-12 |
Vertex Pharmaceuticals Incorporated |
Substituted pyrrolo[2,3-b]pyrazines as ATR kinase inhibitors
|
US8822469B2
(en)
|
2011-06-22 |
2014-09-02 |
Vertex Pharmaceuticals Incorporated |
Pyrrolo[2,3-B]pyrazines useful as inhibitors of ATR kinase
|
CN102924446B
(zh)
*
|
2011-08-11 |
2015-08-26 |
上海吉铠医药科技有限公司 |
Pim激酶抑制剂及其制备方法与在制药中的应用
|
WO2013039854A1
(en)
*
|
2011-09-15 |
2013-03-21 |
Merck Sharp & Dohme Corp. |
Compositions and methods for treating cancer
|
SG2014012579A
(en)
*
|
2011-09-27 |
2014-04-28 |
Hoffmann La Roche |
Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use
|
EP3733185B1
(en)
|
2011-09-30 |
2022-12-07 |
Vertex Pharmaceuticals Incorporated |
Treating non-small cell lung cancer with atr inhibitors
|
EP2751088B1
(en)
|
2011-09-30 |
2016-04-13 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
WO2013049720A1
(en)
|
2011-09-30 |
2013-04-04 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
PT2940017T
(pt)
|
2011-09-30 |
2019-10-31 |
Vertex Pharma |
Processos para a produção de compostos úteis como inibidores de atr quinase
|
EP2751099B1
(en)
|
2011-09-30 |
2017-06-14 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
US8846917B2
(en)
|
2011-11-09 |
2014-09-30 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of ATR kinase
|
WO2013071090A1
(en)
|
2011-11-09 |
2013-05-16 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
EP2776420A1
(en)
|
2011-11-09 |
2014-09-17 |
Vertex Pharmaceuticals Incorporated |
Pyrazine compounds useful as inhibitors of atr kinase
|
US8841449B2
(en)
|
2011-11-09 |
2014-09-23 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of ATR kinase
|
WO2013071094A1
(en)
|
2011-11-09 |
2013-05-16 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
CA2850700C
(en)
*
|
2011-11-30 |
2019-11-12 |
F. Hoffmann-La Roche Ag |
New bicyclic dihydroisoquinoline-1-one derivatives
|
CN108478577A
(zh)
|
2012-04-05 |
2018-09-04 |
沃泰克斯药物股份有限公司 |
可用作atr激酶抑制剂的化合物及其组合疗法
|
AU2013264831B2
(en)
|
2012-05-21 |
2016-04-21 |
Novartis Ag |
Novel ring-substituted N-pyridinyl amides as kinase inhibitors
|
KR20150047609A
(ko)
|
2012-08-30 |
2015-05-04 |
니뽄 신야쿠 가부시키가이샤 |
피리딘 유도체 및 의약
|
DK2904406T3
(en)
|
2012-10-04 |
2018-06-18 |
Vertex Pharma |
METHOD OF DETERMINING THE ATR INHIBITION, INCREASED DNA DAMAGE
|
EP2909202A1
(en)
|
2012-10-16 |
2015-08-26 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
SI3808749T1
(sl)
|
2012-12-07 |
2023-07-31 |
Vertex Pharmaceuticals Incorporated |
Pirazolo(1,5-A)pirimidini za uporabo kot zaviralci ATR kinaze pri zdravljenju rakavih bolezni
|
CN103058913B
(zh)
*
|
2012-12-13 |
2015-09-30 |
江苏弘和药物研发有限公司 |
5-氯异吲哚酮的合成方法
|
US9278950B2
(en)
|
2013-01-14 |
2016-03-08 |
Incyte Corporation |
Bicyclic aromatic carboxamide compounds useful as Pim kinase inhibitors
|
ES2790419T3
(es)
*
|
2013-01-15 |
2020-10-27 |
Incyte Holdings Corp |
Los compuestos de tiazolcarboxamidas y piridinacarboxamida útiles como inhibidores de quinasa de PIM
|
US9242969B2
(en)
|
2013-03-14 |
2016-01-26 |
Novartis Ag |
Biaryl amide compounds as kinase inhibitors
|
WO2014143240A1
(en)
|
2013-03-15 |
2014-09-18 |
Vertex Pharmaceuticals Incorporated |
Fused pyrazolopyrimidine derivatives useful as inhibitors of atr kinase
|
PE20200447A1
(es)
|
2013-05-01 |
2020-02-28 |
Hoffmann La Roche |
Compuestos de biheteroarilo y usos de los mismos
|
WO2014181813A1
(ja)
*
|
2013-05-10 |
2014-11-13 |
武田薬品工業株式会社 |
複素環化合物
|
CA2921959A1
(en)
|
2013-08-23 |
2015-02-26 |
Incyte Corporation |
Furo- and thieno-pyridine carboxamide compounds useful as pim kinase inhibitors
|
US10150737B2
(en)
*
|
2013-11-05 |
2018-12-11 |
Bayer Cropscience Aktiengesellschaft |
Compounds for controlling arthropods
|
SI3077397T1
(sl)
|
2013-12-06 |
2020-02-28 |
Vertex Pharmaceuticals Inc. |
2-amino-6-fluoro-N-(5-fluoro-piridin-3-IL)pirazolo(1,5-A)pirimidin-3- karboksamidna spojina, koristna kot inhibitor kinaze ATR, njena priprava, različne trdne oblike in njeni radioaktivno označeni derivati
|
US10730866B2
(en)
*
|
2014-04-07 |
2020-08-04 |
Purdue Pharma L.P. |
Indole derivatives and use thereof
|
PL3152212T3
(pl)
|
2014-06-05 |
2020-06-15 |
Vertex Pharmaceuticals Inc. |
Radioznakowane pochodne związku 2-amino-6-fluoro-n-[5-fluoro-piridyn-3-ylo]-pirazolo[1,5-a]pirymidino-3-karboksamidu przydatne jako inhibitor kinazy atr, wytwarzanie tego związku i jego różnych postaci stałych
|
SI3157566T1
(sl)
|
2014-06-17 |
2019-08-30 |
Vertex Pharmaceuticals Incorporated |
Postopek za zdravljenje raka z uporabo kombinacije inhibitorjev CHK1 in ATR
|
US9580418B2
(en)
|
2014-07-14 |
2017-02-28 |
Incyte Corporation |
Bicyclic aromatic carboxamide compounds useful as Pim kinase inhibitors
|
WO2016010897A1
(en)
|
2014-07-14 |
2016-01-21 |
Incyte Corporation |
Bicyclic heteroaromatic carboxamide compounds useful as pim kinase inhibitors
|
JO3589B1
(ar)
|
2014-08-06 |
2020-07-05 |
Novartis Ag |
مثبطات كيناز البروتين c وطرق استخداماتها
|
WO2016024350A1
(ja)
|
2014-08-13 |
2016-02-18 |
株式会社エス・ディー・エス バイオテック |
縮合11員環化合物及びそれらを含有する農園芸用殺菌剤
|
UY36294A
(es)
|
2014-09-12 |
2016-04-29 |
Novartis Ag |
Compuestos y composiciones como inhibidores de quinasa
|
WO2016127074A1
(en)
*
|
2015-02-06 |
2016-08-11 |
Blueprint Medicines Corporation |
2-(pyridin-3-yl)-pyrimidine derivatives as ret inhibitors
|
WO2016196244A1
(en)
|
2015-05-29 |
2016-12-08 |
Incyte Corporation |
Pyridineamine compounds useful as pim kinase inhibitors
|
JP6816100B2
(ja)
|
2015-07-16 |
2021-01-20 |
アレイ バイオファーマ、インコーポレイテッド |
RETキナーゼ阻害物質としての置換ピラゾロ[1,5−a]ピリジン化合物
|
AR105967A1
(es)
|
2015-09-09 |
2017-11-29 |
Incyte Corp |
Sales de un inhibidor de pim quinasa
|
WO2017059357A1
(en)
|
2015-09-30 |
2017-04-06 |
Vertex Pharmaceuticals Incorporated |
Method for treating cancer using a combination of dna damaging agents and atr inhibitors
|
WO2017059251A1
(en)
|
2015-10-02 |
2017-04-06 |
Incyte Corporation |
Heterocyclic compounds useful as pim kinase inhibitors
|
CN108697708A
(zh)
|
2015-10-26 |
2018-10-23 |
洛克索肿瘤学股份有限公司 |
Trk抑制剂抗性癌症中的点突变以及与此相关的方法
|
KR20180073689A
(ko)
|
2015-11-02 |
2018-07-02 |
블루프린트 메디신즈 코포레이션 |
Ret의 저해제
|
CN108602765B
(zh)
|
2016-02-08 |
2022-05-03 |
高文有限公司 |
1,2-苯二甲醇化合物的制造方法
|
JP6649967B2
(ja)
|
2016-02-08 |
2020-02-19 |
株式会社エス・ディー・エス バイオテック |
殺菌性組成物
|
GEP20227339B
(en)
|
2016-04-04 |
2022-01-25 |
Loxo Oncology Inc |
Liquid formulations of (s)-n-(5-((r)-2-(2,5-difluorophenyl)-pyrrolidin-1-yl)- pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydro-xypyrrolidine-1-carboxamide
|
US10045991B2
(en)
|
2016-04-04 |
2018-08-14 |
Loxo Oncology, Inc. |
Methods of treating pediatric cancers
|
TN2019000332A1
(en)
|
2016-04-04 |
2021-05-07 |
Loxo Oncology Inc |
Methods of treating pediatric cancers
|
CN107286134B
(zh)
*
|
2016-04-11 |
2019-04-12 |
上海勋和医药科技有限公司 |
2,4-二取代嘧啶衍生物作为cdk抑制剂及其应用
|
MX2018014116A
(es)
|
2016-05-18 |
2019-12-11 |
Array Biopharma Inc |
Procesos para la preparacion de (s)-n-(5-((r)-2-(2,5-difluorofenil )pirrolidin-1-il)-pirazolo[1,5-a]pirimidin-3-il)-3-hidroxipirroli din-1-carboxamida y sales del mismo.
|
US10227329B2
(en)
|
2016-07-22 |
2019-03-12 |
Blueprint Medicines Corporation |
Compounds useful for treating disorders related to RET
|
US10035789B2
(en)
|
2016-07-27 |
2018-07-31 |
Blueprint Medicines Corporation |
Compounds useful for treating disorders related to RET
|
KR20190035752A
(ko)
|
2016-08-03 |
2019-04-03 |
사이머베이 쎄라퓨틱스, 인코퍼레이티드 |
염증성 위장 질환 또는 위장 상태를 치료하기 위한 옥시메틸렌 아릴 화합물
|
WO2018049214A1
(en)
|
2016-09-09 |
2018-03-15 |
Incyte Corporation |
Pyrazolopyridine derivatives as hpk1 modulators and uses thereof for the treatment of cancer
|
TWI704148B
(zh)
|
2016-10-10 |
2020-09-11 |
美商亞雷生物製藥股份有限公司 |
作為ret激酶抑制劑之經取代吡唑并[1,5-a]吡啶化合物
|
JOP20190077A1
(ar)
|
2016-10-10 |
2019-04-09 |
Array Biopharma Inc |
مركبات بيرازولو [1، 5-a]بيريدين بها استبدال كمثبطات كيناز ret
|
JOP20190092A1
(ar)
|
2016-10-26 |
2019-04-25 |
Array Biopharma Inc |
عملية لتحضير مركبات بيرازولو[1، 5-a]بيريميدين وأملاح منها
|
US11053258B2
(en)
|
2016-11-28 |
2021-07-06 |
Bristol-Myers Squibb Company |
Pyrimidine carboxamides as GSK-3 inhibitors
|
US10752609B2
(en)
|
2016-11-28 |
2020-08-25 |
Bristol-Myers Squibb Company |
GSK-3 inhibitors
|
WO2018136661A1
(en)
|
2017-01-18 |
2018-07-26 |
Andrews Steven W |
SUBSTITUTED PYRAZOLO[1,5-a]PYRAZINE COMPOUNDS AS RET KINASE INHIBITORS
|
JOP20190213A1
(ar)
|
2017-03-16 |
2019-09-16 |
Array Biopharma Inc |
مركبات حلقية ضخمة كمثبطات لكيناز ros1
|
EP3461480A1
(en)
|
2017-09-27 |
2019-04-03 |
Onxeo |
Combination of a dna damage response cell cycle checkpoint inhibitors and belinostat for treating cancer
|
TWI791053B
(zh)
|
2017-10-10 |
2023-02-01 |
美商亞雷生物製藥股份有限公司 |
6-(2-羥基-2-甲基丙氧基)-4-(6-(6-((6-甲氧基吡啶-3-基)甲基)-3,6-二氮雜雙環[3.1.1]庚-3-基)吡啶-3-基)吡唑并[1,5-a]吡啶-3-甲腈之結晶形式及其醫藥組合物
|
TWI812649B
(zh)
|
2017-10-10 |
2023-08-21 |
美商絡速藥業公司 |
6-(2-羥基-2-甲基丙氧基)-4-(6-(6-((6-甲氧基吡啶-3-基)甲基)-3,6-二氮雜雙環[3.1.1]庚-3-基)吡啶-3-基)吡唑并[1,5-a]吡啶-3-甲腈之調配物
|
CA3079607A1
(en)
|
2017-10-19 |
2019-04-25 |
Effector Therapeutics, Inc. |
Benzimidazole-indole inhibitors of mnk1 and mnk2
|
CN107641095A
(zh)
*
|
2017-11-16 |
2018-01-30 |
常州合全药业有限公司 |
一种7‑甲氧基异吲哚‑1‑酮的合成方法
|
TW201924683A
(zh)
|
2017-12-08 |
2019-07-01 |
美商英塞特公司 |
用於治療骨髓增生性贅瘤的低劑量組合療法
|
WO2019143994A1
(en)
|
2018-01-18 |
2019-07-25 |
Array Biopharma Inc. |
Substituted pyrazolyl[4,3-c]pyridinecompounds as ret kinase inhibitors
|
US11524963B2
(en)
|
2018-01-18 |
2022-12-13 |
Array Biopharma Inc. |
Substituted pyrazolo[3,4-d]pyrimidines as RET kinase inhibitors
|
TWI802635B
(zh)
|
2018-01-18 |
2023-05-21 |
美商亞雷生物製藥股份有限公司 |
作為ret激酶抑制劑之經取代吡咯并[2,3-d]嘧啶化合物
|
LT3755703T
(lt)
|
2018-02-20 |
2022-10-10 |
Incyte Corporation |
N-(fenil)-2-(fenil)pirimidin-4-karboksamido dariniai ir susiję junginiai, kaip hpk1 inhibitoriai, skirti vėžio gydymui
|
IL302529A
(en)
|
2018-03-08 |
2023-07-01 |
Incyte Corp |
Aminopyrizine diol compounds as PI3K–y inhibitors
|
EP3773589B1
(en)
|
2018-04-03 |
2023-11-01 |
Blueprint Medicines Corporation |
Ret inhibitor for use in treating cancer having a ret alteration
|
US11046658B2
(en)
|
2018-07-02 |
2021-06-29 |
Incyte Corporation |
Aminopyrazine derivatives as PI3K-γ inhibitors
|
EP3829543A1
(en)
|
2018-07-31 |
2021-06-09 |
Loxo Oncology, Inc. |
Spray-dried dispersions and formulations of (s)-5-amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl)-1-(1,1,1-trifluoro propan-2-yl)-1h-pyrazole-4-carboxamide
|
US10899755B2
(en)
|
2018-08-08 |
2021-01-26 |
Incyte Corporation |
Benzothiazole compounds and uses thereof
|
AR116024A1
(es)
*
|
2018-08-29 |
2021-03-25 |
Seal Rock Therapeutics Inc |
Métodos de tratamiento de enfermedades neurodegenerativas
|
JP2022500383A
(ja)
|
2018-09-10 |
2022-01-04 |
アレイ バイオファーマ インコーポレイテッド |
Retキナーゼ阻害剤としての縮合複素環式化合物
|
US11142525B2
(en)
*
|
2018-11-15 |
2021-10-12 |
Pfizer Inc. |
Azalactam compounds as HPK1 inhibitors
|
US20220041579A1
(en)
|
2018-12-19 |
2022-02-10 |
Array Biopharma Inc. |
Substituted quinoxaline compounds as inhibitors of fgfr tyrosine kinases
|
WO2020131627A1
(en)
|
2018-12-19 |
2020-06-25 |
Array Biopharma Inc. |
Substituted pyrazolo[1,5-a]pyridine compounds as inhibitors of fgfr tyrosine kinases
|
US11066394B2
(en)
|
2019-08-06 |
2021-07-20 |
Incyte Corporation |
Solid forms of an HPK1 inhibitor
|
AU2020413333A1
(en)
|
2019-12-27 |
2022-06-16 |
Schrödinger, Inc. |
Cyclic compounds and methods of using same
|
CN111592533B
(zh)
*
|
2020-06-16 |
2021-08-24 |
浙江工业大学 |
1,2,4-噁二唑联吡啶取代苯甲酰胺类化合物及其制备方法和应用
|
WO2022055963A1
(en)
|
2020-09-10 |
2022-03-17 |
Schrödinger, Inc. |
Heterocyclic pericondensed cdc7 kinase inhibitors for the treatment of cancer
|
JP2024505890A
(ja)
|
2021-01-26 |
2024-02-08 |
シュレーディンガー, インコーポレイテッド |
がん、自己免疫及び炎症性障害の治療に有用な三環式化合物
|
TW202300150A
(zh)
|
2021-03-18 |
2023-01-01 |
美商薛定諤公司 |
環狀化合物及其使用方法
|
EP4323358A1
(en)
*
|
2021-04-16 |
2024-02-21 |
Hotspot Therapeutics, Inc. |
Compounds, compositions and methods of treating cancer
|
WO2023030478A1
(zh)
*
|
2021-09-03 |
2023-03-09 |
浙江海正药业股份有限公司 |
吡啶并内酰胺类衍生物及其制备方法和用途
|
WO2023088435A1
(zh)
*
|
2021-11-19 |
2023-05-25 |
成都奥睿药业有限公司 |
三取代吡啶衍生物的制备及作为芳香烃受体调节物的应用
|
WO2023250399A1
(en)
*
|
2022-06-22 |
2023-12-28 |
Tempest Therapeutics, Inc. |
Trex1 inhibitors and uses thereof
|